266 related articles for article (PubMed ID: 35079885)
1. Microvascular invasion of small hepatocellular carcinoma can be preoperatively predicted by the 3D quantification of MRI.
Dong SY; Wang WT; Chen XS; Yang YT; Zhu S; Zeng MS; Rao SX
Eur Radiol; 2022 Jun; 32(6):4198-4209. PubMed ID: 35079885
[TBL] [Abstract][Full Text] [Related]
2. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma.
Lee S; Kim SH; Lee JE; Sinn DH; Park CK
J Hepatol; 2017 Sep; 67(3):526-534. PubMed ID: 28483680
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MR imaging can predict early recurrence after curative resection using image features and texture analysis.
Ahn SJ; Kim JH; Park SJ; Kim ST; Han JK
Abdom Radiol (NY); 2019 Feb; 44(2):539-548. PubMed ID: 30229421
[TBL] [Abstract][Full Text] [Related]
4. A model incorporating histopathology and preoperative gadoxetic acid-enhanced MRI to predict early recurrence of hepatocellular carcinoma without microvascular invasion after curative hepatectomy.
Qu Q; Lu M; Xu L; Zhang J; Liu M; Jiang J; Zhao X; Zhang X; Zhang T
Br J Radiol; 2023 Mar; 96(1144):20220739. PubMed ID: 36877238
[TBL] [Abstract][Full Text] [Related]
5. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
[TBL] [Abstract][Full Text] [Related]
6. Nomogram for Predicting Microvascular Invasion in Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced MRI and Intravoxel Incoherent Motion Imaging.
Zhou L; Qu Y; Quan G; Zuo H; Liu M
Acad Radiol; 2024 Feb; 31(2):457-466. PubMed ID: 37491178
[TBL] [Abstract][Full Text] [Related]
7. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
[TBL] [Abstract][Full Text] [Related]
8. Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm.
Chong HH; Yang L; Sheng RF; Yu YL; Wu DJ; Rao SX; Yang C; Zeng MS
Eur Radiol; 2021 Jul; 31(7):4824-4838. PubMed ID: 33447861
[TBL] [Abstract][Full Text] [Related]
9. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
[TBL] [Abstract][Full Text] [Related]
10. Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI.
Tang M; Zhou Q; Huang M; Sun K; Wu T; Li X; Liao B; Chen L; Liao J; Peng S; Chen S; Feng ST
Eur Radiol; 2021 Nov; 31(11):8615-8627. PubMed ID: 33877387
[TBL] [Abstract][Full Text] [Related]
11. Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma.
Chen J; Zhou J; Kuang S; Zhang Y; Xie S; He B; Deng Y; Yang H; Shan Q; Wu J; Sirlin CB; Wang J
AJR Am J Roentgenol; 2019 Oct; 213(4):821-830. PubMed ID: 31120791
[No Abstract] [Full Text] [Related]
12. Nomogram to Assist in Surgical Plan for Hepatocellular Carcinoma: a Prediction Model for Microvascular Invasion.
Lin S; Ye F; Rong W; Song Y; Wu F; Liu Y; Zheng Y; Siqin T; Zhang K; Wang L; Wu J
J Gastrointest Surg; 2019 Dec; 23(12):2372-2382. PubMed ID: 30820799
[TBL] [Abstract][Full Text] [Related]
13. VICT2 Trait: Prognostic Alternative to Peritumoral Hepatobiliary Phase Hypointensity in HCC.
Jiang H; Wei H; Yang T; Qin Y; Wu Y; Chen W; Shi Y; Ronot M; Bashir MR; Song B
Radiology; 2023 Apr; 307(2):e221835. PubMed ID: 36786702
[TBL] [Abstract][Full Text] [Related]
14. Radiomic analysis based on multi-phase magnetic resonance imaging to predict preoperatively microvascular invasion in hepatocellular carcinoma.
Li YM; Zhu YM; Gao LM; Han ZW; Chen XJ; Yan C; Ye RP; Cao DR
World J Gastroenterol; 2022 Jun; 28(24):2733-2747. PubMed ID: 35979164
[TBL] [Abstract][Full Text] [Related]
15. A nomogram based on multi-modal ultrasound for prediction of microvascular invasion and recurrence of hepatocellular carcinoma.
Zhong X; Peng J; Xie Y; Shi Y; Long H; Su L; Duan Y; Xie X; Lin M
Eur J Radiol; 2022 Jun; 151():110281. PubMed ID: 35395542
[TBL] [Abstract][Full Text] [Related]
16. Assessment of an MR Elastography-Based Nomogram as a Potential Imaging Biomarker for Predicting Microvascular Invasion of Hepatocellular Carcinoma.
Gao S; Zhang Y; Sun W; Jin K; Dai Y; Wang F; Qian X; Han J; Sheng R; Zeng M
J Magn Reson Imaging; 2023 Aug; 58(2):392-402. PubMed ID: 36479914
[TBL] [Abstract][Full Text] [Related]
17. A Nomogram of Magnetic Resonance Imaging for Preoperative Assessment of Microvascular Invasion and Prognosis of Hepatocellular Carcinoma.
Wang L; Zhang Y; Li J; Guo S; Ren J; Li Z; Zhuang X; Xue J; Lei J
Dig Dis Sci; 2023 Dec; 68(12):4521-4535. PubMed ID: 37794295
[TBL] [Abstract][Full Text] [Related]
18. Prediction of HCC microvascular invasion with gadobenate-enhanced MRI: correlation with pathology.
Zhang L; Yu X; Wei W; Pan X; Lu L; Xia J; Zheng W; Jia N; Huo L
Eur Radiol; 2020 Oct; 30(10):5327-5336. PubMed ID: 32367417
[TBL] [Abstract][Full Text] [Related]
19. The role of gadoxetic acid-enhanced MRI features for predicting microvascular invasion in patients with hepatocellular carcinoma.
Yang H; Han P; Huang M; Yue X; Wu L; Li X; Fan W; Li Q; Ma G; Lei P
Abdom Radiol (NY); 2022 Mar; 47(3):948-956. PubMed ID: 34962593
[TBL] [Abstract][Full Text] [Related]
20. Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI.
Jiang H; Wei J; Fu F; Wei H; Qin Y; Duan T; Chen W; Xie K; Lee JM; Bashir MR; Wang M; Song B; Tian J
Liver Int; 2022 May; 42(5):1158-1172. PubMed ID: 35243749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]